BATS BZX Real-Time Price
As of 10:45am ET
| +0.19 / +2.57%|
The 5 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a +45.12% increase from the last price of 7.58.
The current consensus among 7 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.